$697M
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | AMLX Amylyx Pharmaceuticals Inc | 4.6M | +6.3% | $83M | 11.9% |
| 2 | ALMS Alumis Inc | 2.9M | −9.0% | $82M | 11.8% |
| 3 | ABIVAX SA Abivax Sa | 518,865 | −4.4% | $69M | 9.9% |
| 4 | PCVX Vaxcyte Inc | 852,914 | +3.4% | $50M | 7.1% |
| 5 | IMMX Immix Biopharma Inc | 4.7M | +26.1% | $48M | 6.9% |
| 6 | PHVS Pharvaris N V | 1.3M | +9.4% | $45M | 6.5% |
| 7 | JAZZ Jazz Pharmaceuticals Plc | 160,938 | −1.2% | $39M | 5.6% |
| 8 | CELC Celcuity Inc | 370,318 | +31.4% | $39M | 5.6% |
| 9 | IRON Disc Medicine Inc | 524,730 | +16.6% | $38M | 5.5% |
| 10 | CADL Candel Therapeutics Inc | 3.3M | +14.1% | $34M | 4.9% |
| 11 | XFOR X4 Pharmaceuticals Inc | 7.0M | +8.0% | $33M | 4.7% |
| 12 | MNPR Monopar Therapeutics Inc | 311,976 | −9.7% | $29M | 4.1% |
| 13 | DYN Dyne Therapeutics Inc | 1.1M | +9.4% | $23M | 3.4% |
| 14 | TRVI Trevi Therapeutics Inc | 1.1M | — | $20M | 2.8% |
| 15 | ZURA Zura Bio Ltd | 2.1M | +184.0% | $12M | 1.8% |
| 16 | SGMT Sagimet Biosciences Inc | 1.5M | — | $11M | 1.6% |
| 17 | OCS Oculis Holding Ag | 684,880 | +32.5% | $9M | 1.4% |
| 18 | IKT Inhibikase Therapeutics Inc | 3.9M | +0.1% | $8M | 1.1% |
| 19 | VIR Vir Biotechnology Inc | 770,643 | — | $8M | 1.1% |
| 20 | IVVD Invivyd Inc | 8.4M | −23.4% | $7M | 1.0% |
| 21 | ANRO Alto Neuroscience Inc | 182,829 | +105.4% | $5M | 0.7% |
| 22 | MSLE Satellos Bioscience Inc | 350,000 | +0.0% | $3M | 0.4% |
| 23 | OVID Ovid Therapeutics Inc | 663,060 | −84.1% | $2M | 0.3% |